DOCSLIB.ORG

Hnrnp K Co-Immunoprecipitated Transcripts Regulated by BDNF

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hnrnp K Co-Immunoprecipitated Transcripts Regulated by BDNF Table 1-5 - hnRNP K co-immunoprecipitated transcripts regulated by BDNF Gene Symbol Description Fold change LOC302228 PREDICTED: Rattus norvegicus similar to Spindlin-like protein 2 (SPIN-2) (LOC302228), mRNA [XM_229842] 0,085 Tuba3a Rattus norvegicus tubulin, alpha 3A (Tuba3a), mRNA [NM_001040008] 0,204 Fabp12 Rattus norvegicus fatty acid binding protein 12 (Fabp12), mRNA [NM_001134614] 0,215 Slc12a8 Rattus norvegicus solute carrier family 12 (potassium/chloride transporters), member 8 (Slc12a8), mRNA [NM_153625] 0,222 Nog Rattus norvegicus noggin (Nog), mRNA [NM_012990] 0,225 0 Unknown 0,233 Gpx2 Rattus norvegicus glutathione peroxidase 2 (Gpx2), mRNA [NM_183403] 0,251 Ltb Rattus norvegicus lymphotoxin beta (TNF superfamily, member 3) (Ltb), mRNA [NM_212507] 0,255 Ahrr Rattus norvegicus aryl-hydrocarbon receptor repressor (Ahrr), mRNA [NM_001024285] 0,271 0 Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZUC5] [ENSRNOT00000046312] 0,273 Megf8 PREDICTED: Rattus norvegicus multiple EGF-like-domains 8 (Megf8), mRNA [XM_341803] 0,274 Pdcl2 PREDICTED: Rattus norvegicus phosducin-like 2 (Pdcl2), mRNA [XM_001076368] 0,284 Mepe Rattus norvegicus matrix extracellular phosphoglycoprotein (Mepe), mRNA [NM_024142] 0,289 Galr3 Rattus norvegicus galanin receptor 3 (Galr3), mRNA [NM_019173] 0,290 LOC685685 PREDICTED: Rattus norvegicus similar to S100 calcium-binding protein, ventral prostate (LOC685685), mRNA [XM_001064819] 0,306 Sec16b Rattus norvegicus SEC16 homolog B (S. cerevisiae) (Sec16b), mRNA [NM_053571] 0,314 Fam20a Rattus norvegicus family with sequence similarity 20, member A (Fam20a), mRNA [NM_001012237] 0,314 Wnt3 Rattus norvegicus wingless-type MMTV integration site family, member 3 (Wnt3), mRNA [NM_001105715] 0,314 Obsl1 Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZZ80] [ENSRNOT00000020673] 0,315 Ppil4 Rattus norvegicus peptidylprolyl isomerase (cyclophilin)-like 4 (Ppil4), mRNA [NM_001108457] 0,316 0 Unknown 0,320 Rbm41 Rattus norvegicus RNA binding motif protein 41 (Rbm41), mRNA [NM_001109420] 0,321 Pqlc2 Rattus norvegicus PQ loop repeat containing 2 (Pqlc2), mRNA [NM_001108689] 0,325 Rassf9 Rattus norvegicus Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 (Rassf9), mRNA [NM_022959] 0,328 Cpa2 Rattus norvegicus carboxypeptidase A2 (pancreatic) (Cpa2), mRNA [NM_001013083] 0,331 0 PREDICTED: Rattus norvegicus hypothetical protein LOC687735 (LOC687735), mRNA [XM_001079963] 0,332 Ano1 Rattus norvegicus anoctamin 1, calcium activated chloride channel (Ano1), mRNA [NM_001107564] 0,332 Twistnb Rattus norvegicus TWIST neighbor (Twistnb), mRNA [NM_001108707] 0,333 Lgi2 Rattus norvegicus leucine-rich repeat LGI family, member 2 (Lgi2), mRNA [NM_001107219] 0,338 Olr1395 Rattus norvegicus olfactory receptor 1395 (Olr1395), mRNA [NM_001001092] 0,340 0 PREDICTED: Rattus norvegicus dynein, axonemal, heavy polypeptide 9 (Dnah9), mRNA [XM_002727722] 0,342 Tmem79 Rattus norvegicus transmembrane protein 79 (Tmem79), mRNA [NM_001033896] 0,343 LOC682131 PREDICTED: Rattus norvegicus similar to KRAB-zinc finger protein (LOC682131), mRNA [XM_001060021] 0,344 Gusb Rattus norvegicus glucuronidase, beta (Gusb), mRNA [NM_017015] 0,345 Pola1 Rattus norvegicus polymerase (DNA directed), alpha 1 (Pola1), mRNA [NM_053479] 0,346 Tdrkh Rattus norvegicus tudor and KH domain containing (Tdrkh), mRNA [NM_001014038] 0,349 Top2a Rattus norvegicus topoisomerase (DNA) II alpha (Top2a), mRNA [NM_022183] 0,351 Lrrc55 Rattus norvegicus leucine rich repeat containing 55 (Lrrc55), mRNA [NM_001122975] 0,352 Alpk3 Rattus norvegicus alpha-kinase 3 (Alpk3), mRNA [NM_001191895] 0,353 0 Rab3 GTPase-activating protein catalytic subunit [Source:UniProtKB/Swiss-Prot;Acc:P69735] [ENSRNOT00000005289] 0,353 0 Unknown 0,353 Nob1 Rattus norvegicus NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) (Nob1), mRNA [NM_199086] 0,353 Gnb1l Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZSP4] [ENSRNOT00000002596] 0,356 Cyb5r4 Rattus norvegicus cytochrome b5 reductase 4 (Cyb5r4), mRNA [NM_133427] 0,358 Gpatch4 Rattus norvegicus G patch domain containing 4 (Gpatch4), mRNA [NM_001024979] 0,360 Plac1l PREDICTED: Rattus norvegicus placenta-specific 1-like (Plac1l), mRNA [XM_001076035] 0,360 Kif1c Rattus norvegicus kinesin family member 1C (Kif1c), mRNA [NM_145877] 0,361 PREDICTED: Rattus norvegicus similar to Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (LOC679886), mRNA Chmp4bl1 0,363 [XM_002726346] Hexim2 Rattus norvegicus hexamthylene bis-acetamide inducible 2 (Hexim2), mRNA [NM_001107054] 0,363 Atl3 Rattus norvegicus atlastin GTPase 3 (Atl3), mRNA [NM_001044241] 0,363 Slc25a37 Rattus norvegicus solute carrier family 25, member 37 (Slc25a37), nuclear gene encoding mitochondrial protein, mRNA [NM_001013996] 0,363 Ctxn3 Rattus norvegicus cortexin 3 (Ctxn3), mRNA [NM_001134696] 0,365 RGD1565690 Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZF21] [ENSRNOT00000039316] 0,365 0 PREDICTED: Rattus norvegicus similar to RIKEN cDNA D230037D09 gene (RGD1566396), mRNA [XM_001067433] 0,365 Alb Rattus norvegicus albumin (Alb), mRNA [NM_134326] 0,366 0 Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZKC7] [ENSRNOT00000064975] 0,366 Mapk12 Rattus norvegicus mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_021746] 0,367 Stfa2l1 Rattus norvegicus stefin A2-like 1 (Stfa2l1), mRNA [NM_001004129] 0,369 Abcf2 Rattus norvegicus ATP-binding cassette, subfamily F (GCN20), member 2 (Abcf2), nuclear gene encoding mitochondrial protein, mRNA [NM_001109666] 0,369 0 Unknown 0,373 Mcm6 Rattus norvegicus minichromosome maintenance complex component 6 (Mcm6), mRNA [NM_017287] 0,374 LOC685953 Platelet glycoprotein 4 [Source:UniProtKB/Swiss-Prot;Acc:Q07969] [ENSRNOT00000066224] 0,375 Hspa2 Rattus norvegicus heat shock protein 2 (Hspa2), mRNA [NM_021863] 0,376 Lrrc48 Rattus norvegicus leucine rich repeat containing 48 (Lrrc48), mRNA [NM_001013857] 0,376 Btg3 Rattus norvegicus BTG family, member 3 (Btg3), mRNA [NM_019290] 0,377 Mcpt1l4 Mast cell protease 1-like 4 [Source:UniProtKB/TrEMBL;Acc:Q6IE57] [ENSRNOT00000043182] 0,379 Fam53a Rattus norvegicus family with sequence similarity 53, member A (Fam53a), mRNA [NM_001107228] 0,379 0 Unknown 0,380 Manba Rattus norvegicus mannosidase, beta A, lysosomal (Manba), mRNA [NM_001031655] 0,381 LOC691692 PREDICTED: Rattus norvegicus hypothetical protein LOC691692 (LOC691692), mRNA [XM_001079285] 0,381 Piwil2 Rattus norvegicus piwi-like 2 (Drosophila) (Piwil2), mRNA [NM_001107276] 0,382 0 Unknown 0,383 Med6 Rattus norvegicus mediator complex subunit 6 (Med6), mRNA [NM_001106742] 0,386 0 Unknown 0,387 Bclaf1 Rattus norvegicus BCL2-associated transcription factor 1 (Bclaf1), mRNA [NM_001047852] 0,387 Itm2a Rattus norvegicus integral membrane protein 2A (Itm2a), mRNA [NM_001025712] 0,389 Pcdha1 Rattus norvegicus protocadherin alpha 1 (Pcdha1), mRNA [NM_199503] 0,390 RGD1305627 Rattus norvegicus hypothetical LOC314467 (RGD1305627), mRNA [NM_001134560] 0,391 LOC502876 PREDICTED: Rattus norvegicus similar to protein phosphatase 1, regulatory subunit 15B (LOC502876), miscRNA [XR_086238] 0,391 Cenpl Rattus norvegicus centromere protein L (Cenpl), mRNA [NM_001033061] 0,392 Rnf168 Rattus norvegicus ring finger protein 168 (Rnf168), mRNA [NM_001127597] 0,393 Glt8d3 Rattus norvegicus glycosyltransferase 8 domain containing 3 (Glt8d3), mRNA [NM_001100887] 0,393 N4bp2 Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZLS6] [ENSRNOT00000031792] 0,393 Eml4 Rattus norvegicus echinoderm microtubule associated protein like 4 (Eml4), mRNA [NM_001108008] 0,394 Slco4a1 Rattus norvegicus solute carrier organic anion transporter family, member 4a1 (Slco4a1), mRNA [NM_133608] 0,394 Stim2 Rattus norvegicus stromal interaction molecule 2 (Stim2), mRNA [NM_001105750] 0,395 Acan Rattus norvegicus aggrecan (Acan), mRNA [NM_022190] 0,396 RGD1565309 PREDICTED: Rattus norvegicus similar to hypothetical protein MGC33370 (RGD1565309), mRNA [XM_573520] 0,396 0 predicted gene 884 Gene [Source:MGI Symbol;Acc:MGI:2685730] [ENSRNOT00000043156] 0,396 Clgn Rattus norvegicus calmegin (Clgn), mRNA [NM_001109472] 0,397 0 Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D4A3R8] [ENSRNOT00000049208] 0,399 C1ql4 Complement component 1, q subcomponent-like 4 (Predicted)Uncharacterized protein [Source:UniProtKB/TrEMBL;Acc:D3ZMN4] [ENSRNOT00000003152] 0,399 Gas2l1 Rattus norvegicus growth arrest-specific 2 like 1 (Gas2l1), mRNA [NM_001108365] 0,400 0 Unknown 0,400 Ttk Rattus norvegicus Ttk protein kinase (Ttk), mRNA [NM_001108172] 0,400 Crebzf Rattus norvegicus CREB/ATF bZIP transcription factor (Crebzf), mRNA [NM_001106279] 0,401 Fanca Rattus norvegicus Fanconi anemia, complementation group A (Fanca), mRNA [NM_001108455] 0,403 Osbpl11 Rattus norvegicus oxysterol binding protein-like 11 (Osbpl11), mRNA [NM_001107090] 0,403 Tfeb Rattus norvegicus transcription factor EB (Tfeb), mRNA [NM_001025707] 0,403 Ifi44 Rattus norvegicus interferon-induced protein 44 (Ifi44), mRNA [NM_001107729] 0,403 0 Unknown 0,404 LOC679824 PREDICTED: Rattus norvegicus hypothetical protein LOC679824 (LOC679824), miscRNA [XR_085739] 0,405 0 Unknown 0,405 Ndufb7 Rattus norvegicus NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (Ndufb7), nuclear gene encoding mitochondrial protein, mRNA [NM_001108442] 0,405 0 Unknown 0,406 Rrs1 Rattus norvegicus RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) (Rrs1), mRNA [NM_001079699] 0,406 LOC100362255 PREDICTED: Rattus norvegicus G protein-coupled receptor 98 (LOC100362255), mRNA [XM_002729130]
Load more

Recommended publications
  • C8cc08685k1.Pdf
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2018 Supporting Information Minimalist Linkers Suitable for Irreversible Inhibitors in Simultaneous Proteome Profiling, Live-Cell Imaging and Drug Screening Cuiping Guo,Yu Chang, Xin Wang, Chengqian Zhang, Piliang Hao*, Ke Ding and Zhengqiu Li* School of Pharmacy, Jinan University, Guangzhou, China 510632 *Corresponding author ([email protected]) 1. General Information All chemicals were purchased from commercial vendors and used without further purification, unless indicated otherwise. All reactions requiring anhydrous conditions were carried out under argon or nitrogen atmosphere using oven-dried glassware. AR-grade solvents were used for all reactions. Reaction progress was monitored by TLC on pre-coated silica plates (Merck 60 F254 nm, 0.25 µm) and spots were visualized by UV, iodine or other suitable stains. Flash column chromatography was carried out using silica gel (Qingdao Ocean). All NMR spectra (1H-NMR, 13C-NMR) were recorded on Bruker 300 MHz/400 MHz NMR spectrometers. Chemical shifts were reported in parts per million (ppm) referenced with respect to appropriate internal standards or residual solvent peaks (CDCl3 = 7.26 ppm, DMSO-d6 = 2.50 ppm). The following abbreviations were used in reporting spectra, br s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublets). Mass spectra were obtained on Agilent LC-ESI-MS system. All analytical HPLC were carried out on Agilent system. Water with 0.1% TFA and acetonitrile with 0.1% TFA were used as eluents and the flow rate was 0.5 mL/min.
    [Show full text]
  • Small Cell Ovarian Carcinoma: Genomic Stability and Responsiveness to Therapeutics
    Gamwell et al. Orphanet Journal of Rare Diseases 2013, 8:33 http://www.ojrd.com/content/8/1/33 RESEARCH Open Access Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics Lisa F Gamwell1,2, Karen Gambaro3, Maria Merziotis2, Colleen Crane2, Suzanna L Arcand4, Valerie Bourada1,2, Christopher Davis2, Jeremy A Squire6, David G Huntsman7,8, Patricia N Tonin3,4,5 and Barbara C Vanderhyden1,2* Abstract Background: The biology of small cell ovarian carcinoma of the hypercalcemic type (SCCOHT), which is a rare and aggressive form of ovarian cancer, is poorly understood. Tumourigenicity, in vitro growth characteristics, genetic and genomic anomalies, and sensitivity to standard and novel chemotherapeutic treatments were investigated in the unique SCCOHT cell line, BIN-67, to provide further insight in the biology of this rare type of ovarian cancer. Method: The tumourigenic potential of BIN-67 cells was determined and the tumours formed in a xenograft model was compared to human SCCOHT. DNA sequencing, spectral karyotyping and high density SNP array analysis was performed. The sensitivity of the BIN-67 cells to standard chemotherapeutic agents and to vesicular stomatitis virus (VSV) and the JX-594 vaccinia virus was tested. Results: BIN-67 cells were capable of forming spheroids in hanging drop cultures. When xenografted into immunodeficient mice, BIN-67 cells developed into tumours that reflected the hypercalcemia and histology of human SCCOHT, notably intense expression of WT-1 and vimentin, and lack of expression of inhibin. Somatic mutations in TP53 and the most common activating mutations in KRAS and BRAF were not found in BIN-67 cells by DNA sequencing.
    [Show full text]
  • Reprogramming of Trna Modifications Controls the Oxidative Stress Response by Codon-Biased Translation of Proteins
    Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Chan, Clement T.Y. et al. “Reprogramming of tRNA Modifications Controls the Oxidative Stress Response by Codon-biased Translation of Proteins.” Nature Communications 3 (2012): 937. As Published http://dx.doi.org/10.1038/ncomms1938 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/76775 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins Clement T.Y. Chan,1,2 Yan Ling Joy Pang,1 Wenjun Deng,1 I. Ramesh Babu,1 Madhu Dyavaiah,3 Thomas J. Begley3 and Peter C. Dedon1,4* 1Department of Biological Engineering, 2Department of Chemistry and 4Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; 3College of Nanoscale Science and Engineering, University at Albany, SUNY, Albany, NY 12203 * Corresponding author: PCD, Department of Biological Engineering, NE47-277, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; tel 617-253-8017; fax 617-324-7554; email [email protected] 2 ABSTRACT Selective translation of survival proteins is an important facet of cellular stress response. We recently demonstrated that this translational control involves a stress-specific reprogramming of modified ribonucleosides in tRNA.
    [Show full text]
  • Protein Name Accession Number Molecular Weight Myovi-GTD
    MyoVI-GTD MyoVI-GTD MyoVa-MGT MyoVa-MGT Molecular Spectral Unique Spectral Unique Protein Name Accession Number Weight Counts Peptides Counts Peptides Dync1h1 Cytoplasmic dynein 1 heavy chain 1 IPI00119876 532 kDa 310 121 515 182 Spna2 Spectrin alpha 2 IPI00757353 285 kDa 853 170 597 149 Myo5a 215 kDa protein IPI00875222 215 kDa 162 47 874 109 AU042671 hypothetical protein LOC269700 isoform 1 IPI00762814 453 kDa 2 2 231 104 Spnb2 Isoform 1 of Spectrin beta chain, brain 1 IPI00319830 274 kDa 505 122 347 100 Dmxl2 Isoform 1 of DmX-like protein 2 IPI00853932 338 kDa 63 38 251 100 Cltc Clathrin heavy chain 1 IPI00169916 (+1) 192 kDa 1994 138 565 90 Mtap2 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530026F16 product:microtubule-associated protein 2, full insert sequenceIPI00894724 199 kDa 229 82 258 74 Mtap1a Isoform 1 of Microtubule-associated protein 1A IPI00408909 (+1) 300 kDa 310 86 214 74 Itpr1 Isoform 4 of Inositol 1,4,5-trisphosphate receptor type 1 IPI00230019 (+3) 311 kDa 37 18 155 73 Huwe1 HECT, UBA and WWE domain containing 1 IPI00463909 (+1) 483 kDa 5 5 91 69 Fasn Fatty acid synthase IPI00113223 272 kDa 24 17 140 68 Usp9x Ubiquitin carboxyl-terminal hydrolase IPI00798468 291 kDa 68 45 98 65 Lrp1 Prolow-density lipoprotein receptor-related protein 1 precursor IPI00119063 505 kDa 92 53 109 62 Myh10 Myosin-10 IPI00515398 (+1) 229 kDa 65 40 98 59 Mical1 NEDD9-interacting protein with calponin homology and LIM domains IPI00116371 117 kDa 2 2 203 57 Plec1 Isoform PLEC-1I of Plectin-1 IPI00229509 (+10)
    [Show full text]
  • Implications in Parkinson's Disease
    Journal of Clinical Medicine Review Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease Silvia Paciotti 1,2 , Elisabetta Albi 3 , Lucilla Parnetti 1 and Tommaso Beccari 3,* 1 Laboratory of Clinical Neurochemistry, Department of Medicine, University of Perugia, Sant’Andrea delle Fratte, 06132 Perugia, Italy; [email protected] (S.P.); [email protected] (L.P.) 2 Section of Physiology and Biochemistry, Department of Experimental Medicine, University of Perugia, Sant’Andrea delle Fratte, 06132 Perugia, Italy 3 Department of Pharmaceutical Sciences, University of Perugia, Via Fabretti, 06123 Perugia, Italy; [email protected] * Correspondence: [email protected] Received: 29 January 2020; Accepted: 20 February 2020; Published: 21 February 2020 Abstract: Ceramides are a family of bioactive lipids belonging to the class of sphingolipids. Sphingolipidoses are a group of inherited genetic diseases characterized by the unmetabolized sphingolipids and the consequent reduction of ceramide pool in lysosomes. Sphingolipidoses include several disorders as Sandhoff disease, Fabry disease, Gaucher disease, metachromatic leukodystrophy, Krabbe disease, Niemann Pick disease, Farber disease, and GM2 gangliosidosis. In sphingolipidosis, lysosomal lipid storage occurs in both the central nervous system and visceral tissues, and central nervous system pathology is a common hallmark for all of them. Parkinson’s disease, the most common neurodegenerative movement disorder, is characterized by the accumulation and aggregation of misfolded α-synuclein that seem associated to some lysosomal disorders, in particular Gaucher disease. This review provides evidence into the role of ceramide metabolism in the pathophysiology of lysosomes, highlighting the more recent findings on its involvement in Parkinson’s disease. Keywords: ceramide metabolism; Parkinson’s disease; α-synuclein; GBA; GLA; HEX A-B; GALC; ASAH1; SMPD1; ARSA * Correspondence [email protected] 1.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Seq2pathway Vignette
    seq2pathway Vignette Bin Wang, Xinan Holly Yang, Arjun Kinstlick May 19, 2021 Contents 1 Abstract 1 2 Package Installation 2 3 runseq2pathway 2 4 Two main functions 3 4.1 seq2gene . .3 4.1.1 seq2gene flowchart . .3 4.1.2 runseq2gene inputs/parameters . .5 4.1.3 runseq2gene outputs . .8 4.2 gene2pathway . 10 4.2.1 gene2pathway flowchart . 11 4.2.2 gene2pathway test inputs/parameters . 11 4.2.3 gene2pathway test outputs . 12 5 Examples 13 5.1 ChIP-seq data analysis . 13 5.1.1 Map ChIP-seq enriched peaks to genes using runseq2gene .................... 13 5.1.2 Discover enriched GO terms using gene2pathway_test with gene scores . 15 5.1.3 Discover enriched GO terms using Fisher's Exact test without gene scores . 17 5.1.4 Add description for genes . 20 5.2 RNA-seq data analysis . 20 6 R environment session 23 1 Abstract Seq2pathway is a novel computational tool to analyze functional gene-sets (including signaling pathways) using variable next-generation sequencing data[1]. Integral to this tool are the \seq2gene" and \gene2pathway" components in series that infer a quantitative pathway-level profile for each sample. The seq2gene function assigns phenotype-associated significance of genomic regions to gene-level scores, where the significance could be p-values of SNPs or point mutations, protein-binding affinity, or transcriptional expression level. The seq2gene function has the feasibility to assign non-exon regions to a range of neighboring genes besides the nearest one, thus facilitating the study of functional non-coding elements[2]. Then the gene2pathway summarizes gene-level measurements to pathway-level scores, comparing the quantity of significance for gene members within a pathway with those outside a pathway.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • Gpr161 Anchoring of PKA Consolidates GPCR and Camp Signaling
    Gpr161 anchoring of PKA consolidates GPCR and cAMP signaling Verena A. Bachmanna,1, Johanna E. Mayrhofera,1, Ronit Ilouzb, Philipp Tschaiknerc, Philipp Raffeinera, Ruth Röcka, Mathieu Courcellesd,e, Federico Apeltf, Tsan-Wen Lub,g, George S. Baillieh, Pierre Thibaultd,i, Pia Aanstadc, Ulrich Stelzlf,j, Susan S. Taylorb,g,2, and Eduard Stefana,2 aInstitute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, 6020 Innsbruck, Austria; bDepartment of Chemistry and Biochemistry, University of California, San Diego, CA 92093; cInstitute of Molecular Biology, University of Innsbruck, 6020 Innsbruck, Austria; dInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada H3C 3J7; eDépartement de Biochimie, Université de Montréal, Montreal, QC, Canada H3C 3J7; fOtto-Warburg Laboratory, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany; gDepartment of Pharmacology, University of California, San Diego, CA 92093; hInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom; iDepartment of Chemistry, Université de Montréal, Montreal, QC, Canada H3C 3J7; and jInstitute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, 8010 Graz, Austria Contributed by Susan S. Taylor, May 24, 2016 (sent for review February 18, 2016; reviewed by John J. G. Tesmer and Mark von Zastrow) Scaffolding proteins organize the information flow from activated G accounts for nanomolar binding affinities to PKA R subunit dimers protein-coupled receptors (GPCRs) to intracellular effector cascades (12, 13). Moreover, additional components of the cAMP signaling both spatially and temporally. By this means, signaling scaffolds, such machinery, such as GPCRs, adenylyl cyclases, and phosphodiester- as A-kinase anchoring proteins (AKAPs), compartmentalize kinase ases, physically interact with AKAPs (1, 5, 11, 14).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
    Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN.
    [Show full text]
  • ASPA Gene Aspartoacylase
    ASPA gene aspartoacylase Normal Function The ASPA gene provides instructions for making an enzyme called aspartoacylase. In the brain, this enzyme breaks down a compound called N-acetyl-L-aspartic acid (NAA) into aspartic acid (an amino acid that is a building block of many proteins) and another molecule called acetic acid. The production and breakdown of NAA appears to be critical for maintaining the brain's white matter, which consists of nerve fibers surrounded by a myelin sheath. The myelin sheath is the covering that protects nerve fibers and promotes the efficient transmission of nerve impulses. The precise function of NAA is unclear. Researchers had suspected that it played a role in the production of the myelin sheath, but recent studies suggest that NAA does not have this function. The enzyme may instead be involved in the transport of water molecules out of nerve cells (neurons). Health Conditions Related to Genetic Changes Canavan disease More than 80 mutations in the ASPA gene are known to cause Canavan disease, which is a rare inherited disorder that affects brain development. Researchers have described two major forms of this condition: neonatal/infantile Canavan disease, which is the most common and most severe form, and mild/juvenile Canavan disease. The ASPA gene mutations that cause the neonatal/infantile form severely impair the activity of aspartoacylase, preventing the breakdown of NAA and allowing this substance to build up to high levels in the brain. The mutations that cause the mild/juvenile form have milder effects on the enzyme's activity, leading to less accumulation of NAA.
    [Show full text]